(Q35707526)

9 August 2017

title

An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand. (English)

1 reference

9 August 2017

0 references

2

Amanda Wheeler

1 reference

9 August 2017

Verity Humberstone

1

1 reference

9 August 2017

Tim Lambert

series ordinal

3

1 reference

9 August 2017

publication date

1 April 2004

1 reference

Australian and New Zealand Journal of Psychiatry

9 August 2017

published in

1 reference

9 August 2017

volume

38

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

240-245

1 reference

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Impact on Thai psychiatrists of passive dissemination of a clinical practice guideline on prescribing attitudes in treatment-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Discharge prescribing practices: Comparing a research ward to general treatment wards

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Comparative Doses and Costs of Antipsychotic Medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Recent patterns and predictors of antipsychotic medication regimens used to treat schizophrenia and other psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Italian Collaborative Study Group on the Outcome of Severe Mental Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

Atypical antipsychotics in ordinary clinical practice: a pharmaco-epidemiologic survey in a south London service

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ.1440-1614.2004.01340.X

10.1080/J.1440-1614.2004.01340.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference